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The cardiac pacemaker is the first prosthetic device powered by nuclear energy to achieve practical apphcation m man Several manufacturers have developed ^^*Pu-powered pacemakers Since plutonium is, by definition, "special nuclear material," pacemakers containing ^^*Pu are subject to Nuclear Regulatory Commission (NRC) regulations in Title 10, Code of Federal Regulations, Part 70 (10 CFR 70) Pnor to hcensing plutonium-powered pacemakers for routine use, the NRC IS required to write an environmental statement discussing aspects of their impact on the environment This program in the Health Physics Division of ORNL is to provide NRC with technical assistance m completing this environmental assessment This assistance primarily includes performing an environmental risk assessment and a benefit analysis BACKGROUND Several tens of thousands of cardiac patients in the United States have been restored to normal and useful lives with the implantation of cardiac pacemakers Pacemaker implantations are indicated for patients suffering from certain forms of cardiac arrhythmias In most cases, these disturbances are associated with a lack of effective, coordinated contraction of the heart's lower chamber in synchrony with its upper chambers Conventional pacemakers are powered by mercury batteries (mercuric oxide-zinc) and require periodic surgical replacement of the entire pacemaker upon the loss, or impending loss, of battery output The present expected service lifetime of conventional paccinakers including new improved batteries ranges from 1V2 to 6 years (service lifetimes based on the period of time the manufacturer will grarantee the unit) A rechargeable pacemaker using a nickel-cadmium battery has recently been developed with a hfetime of 10 years The expected lifetimes of plutonium-powered cardiac pacemakers range from 10 to 20 years The NRC is currently licensing the implantation of plutonium-powered pacemakers under a limited investigational program until it can be estabhshed that (1) nuclear-powered pacemakers are safe and reliable, (2) routine use will not subject the pubhc to any undue risk, and (3) the benefits derived from the use of nuclear-powered units will outweigh the risk to the public Pursuant to NRC's responsibihties under the National Environmental Pohcy Act of 1969 (Public Law 91-190), the Council of Environmental Quahty's guidelines of August 1, 1973 (38 F R 20550) , and 10 CFR 51 of the Commission's regulations, environmental statements are required to be prepared prior to taking major Federal actions that may affect the quality of the human environment Authorizing the routine use of nuclear-powered pacemakers (beyond the present investigational use) IS considered to be a major Federal action Therefore, an environmental statement has been written which describes and evaluates the environmental consequences of use of plutonium fuel m cardiac pacemakers Three major subjects are identified from the 10 CFR 51 guidelines as being pertinent to this environmental statement These are (1) potential impacts on the environment, (2) a cost-benefit and benefit-risk balance, and (3) available alternatives to such use With respect to environmental impacts, three are identified (1) radiation exposure to the patients from implanted pacemakers, (2) exposure to the public from normal use, and (3) release of plutonium from accidental or abnormal events
ENVIRONMENTAL ASSESSMENT
The radiation doses from a Medtronics model 9000 pulse generator containing 173 2 mg of plutonium of 90% by weight "*Pu and 0 26 ppm "*Pu were determined by Battelle Pacific Northwest Labora-tories.' Integrated total dose equivalents to various organs for 5-, 10-, 15-, and 20-year periods are shown in Table 31 .1 for a subcutaneous pacemaker implant above the left pectoral muscle (implant location shown in Fig. 31.1) .
The radiation level at the skin surface of a patient with an implanted pacemaker is 1 to 2 millirems/hr, and at a distance of 20 cm from a patient's body the radiation from a pacemaker is less than the ambient background radiation.
Spouses of pacemaker patients will receive the largest radiation exposure. This is because their contact with the patients is more frequent and at closer distances than contacts by other persons. The average annual exposure to a spouse from a patient was calculated by Battelle Pacific Northwest Laboratories to be 5 to 15 millirems/year,^ and most of this exposure is received during the sleeping hours, when the spouse is usually within a few feet of the patient.
All other individuals associating with pacemaker patients will be exposed to much lower levels of radiation. Dose calculations for various categories of people with whom pacemaker patients are likely to come into contact during their daily activities aie shown in Table 31 .2. With respect to the general public, the radiation dose attributable to pacemaker patients will be negligible.
Pacemakers are required to be designed to high standards such that they can withstand hypothetical credible accidents. Also, requirements are placed on the fuel form to assure that its physical and chemical form be such that it will be as nondispersible and nontransportable as is practicable. Plutonium dioxide, a chemically unreactive form of plutonium, is compressed and fired into a hard, glossy ceramic pellet to reduce the likelihood of wide-scale fuel dispersion in the event of an accidental capsule breach. To provide a high degree of assurance that the plutonium fuel will be contained under any accident condition, the fuel pellets are clad with two or three layers of refractory metals. Manufacturers are required to demonstrate that their pacemaker model will be able to maintain fuel capsule integrity over a spectrum of mechanical, thermal, and environmental stresses.
The possibihty that stresses may be sufficient to breach the fuel capsule does exist. For this reason, a risk assessment of credible events and their probability of occurrence was performed. A probabilistic model was developed to establish probabiMties of and potential hazards from a capsule breach. A block diagram of this analysis is shown in Fig. 31 .2.
Radiological consequences are calculated by combining accident statistics from mortality tables with probabilities of capsule breach by different stresses and source-term information in the event of a breach.
The cremation of a deceased patient's body with his pacemaker still intact is deemed to be the most likely incident to result in the dispersion of plutonium fines into the environment. The probability of a pacemaker's fuel capsule rupturing in a crematory furnace is dependent upon a number of factors. These are the probability of a patient death per year, the probability of a body being cremated after death, the probability that the pacemaker wOl not be removed prior to cremation, and the probability that the cremation furnace may exceed the prototype test temperature for a sufficiently long time to rupture the fuel capsule. These four probabilities combine to an overall expecta- "Dose will vary depending upon the plutonium content and fuel characteristics of a particular pacemaker model. ^Integrated dose using 8 Ci of plutonium, which is maximum plutonium used in any battery.
•^A patient is predicted to associate with approximately 30 persons during his daily activities ''Total dose to U.S. population of 210,000,000 excluding dose to patients tion of one breach m 20 years from a pacemaker population of 10,000 patients Figure 31 3 shows the nsk-logic progression for a fuel-capsule breach during cremation If a fuel capsule were to be breached m a crematory furnace, most of any plutonium fines would remain in the retort or entramment system of the furnace By assuming that all of the respirable size particles (<10 /im from source-term information) leave the furance stack, the maximum dose commitment to an individual m the vicinity of a crematorium is calculated to be 420 millirems (50-year dose commitment) The average 50-year dose commitment to individuals exposed to plutonium particles m the gaseous plume out to 2000 m from a crematorium is 7 5 millirems These dose commitments are calculated from a computer code given settling velocities and release rate of plutonium fines Near neutral weather stability and a 4 m/sec wind velocity are used in the calculation, for they are reasonably representative of average U S meteorological conditions The inhalation model employed to calculate absorbed dose is a representation of the lung model developed by the Inter- The benefits that can be realized from the use of plutonium-powered cardiac pacemakers are related to the long hfetime of the plutonium-powered battery, which results in the reduction or elimination of the need for pacemakers to be replaced because of battery depletion The principal benefit derived from the use of plutonium-powered pacemakers is the number of lives saved by the decreased surgical mortality associated with decreased need for replacement operations, the attendant reduction in surgical and medical complications, and the reduction of patient pain, suffering, and anxiety
Mortalities from surgical procedures including postoperative follow-up vary from 1 to 4%, with a mean value of approximately 3% A surgical mortality rate of 1% IS used for reimplantation operations because they involve a reduced risk due to simpler procedures (More recent statistics indicate that these mortalities are much lower)
These mortality rates were used in a computer program which was developed to compare expected patient mortalities for groups of patients using various with a I'/j-to 3-year service life The lives saved for other combinations of expected pacemaker service lives may be obtained from Table 31 3 Data for these computations were abstracted from literature references This literature represents experience with approximately 20,000 patients with conventional-powered pacemakers The input data for the computation included (1) estimated mortality of pace maker patients from causes not pacemaker-related, (2) replacement of pacemakers due to battery depletion at a distribution of times over 1 Vj to 3 years as reported in the literature and at the other designated replacement intervals, (3) pacemaker replacements because of random failures at the rate of 2% annually for all types, (4) a patient mortality rate due to pacemaker system failures of 0 1% armually, (5) mortality rates due to initial implantation surgery of 3% and due to reimplantation surgery of 1%, and (6) the addition of new patients to the groups to replace patients lost from the groups by death Pacemaker patient populations are not representative of the U S populace with respect to age distribution The age distribution of patients submitted by Medtronics, Inc ,^ was used m this study since their data cover the largest statistical population of patients (1989 patients) and are similar to other reported age distnbutions Each patient group was subdivided into five-year age subgroups The mortality rate from natural attrition for each age subgroup was assumed to be the same as the U S mortality rate for the subgroup The patient age distribution, U S populace mortality rates and expected patient deaths from natural attrition per age subgroup are presented in Table 31 pacemaker replacement intervals The results of these calculations can be used to determine the lives saved by pacemakers with one replacement interval as compared with pacemakers with a different replacement period Results of these calculations are shown in Table 31 3 For example, for an equilibrium population of 10,000 pacemaker patients, the use of plutonium-powered pacemakers with an expected service life of 10 years would save, in 10 years, an estimated 373 lives (1100 -727) when compared with conventional pacemakers The patient population withm each subgroup was adjusted yearly in this computer study for 20 years These adjustments included subtracting yearly the total number of patient deaths m each group from the patient population of that age group and then promoting an appropriate fraction of the remaining patients into the next older subgroups The total number of patient mortalities per age subgroup is a sum of patient deaths from natural attritions deaths due to risk of surgery, and deaths caused from pacemaker failures
The above procedures for adjusting the patient populations yearly assume that pacemaker patient mortality rates due to natural attntion are the same as those of the U S populace of the same ages This appears to be valid, for physicians have reported that many patients for whom pacemakers are implanted return to a relatively normal life, that is, to activities considered appropriate for their age, and they enjoy normal longevity patterns SUMMARY The medical benefits (reduction of patients' surgical risk of death, complications, pam, suffering, and anxiety) and the environmental nsks (radiation exposure to the population and patients) of using plutonium-powered cardiac pacemakers are difficult to quantify on a basis that can be directly compared
For a pacemaker population of 10,000 patients plutonium-powered pacemakers with a 10-to 20-year service life would save six to nine lives annually when compared with conventional pacemakers with a 6-year service life The total radiation exposure to the U S population from 10,000 plutonium-powered pacemaker implants would be 258 man-rems/year Exposures to others from pacemakers implanted m patients accounts for 256 man-rems/year of this total, with approximately 2 man-rems resulting from postulated breaches of fuel capsules The total-body exposure to 10,000 patients will exceed 1000 man-rems/year, but this is a voluntary risk
The NRC has not yet issued its final position on the use of plutonium-powered cardiac pacemakers There appears to be an alternative pacemaker, the rechargeable nickel-cadmium battery-powered pacemaker, which offers a postulated service lifetime similar to that of the plutonium-powered unit However, rechargeable pacemakers are not suitable for all patients requiring a long-lived pacemaker (Up to about 25% of patients requiring pacemakers can fully use a unit's lifetime of 10 to 20 years)
There is a small population of pacemaker patients which can benefit from the use of plutonium-powered cardiac pacemakers, and the benefits to these patients are substantially greater than the risks to the environment, which are comparatively small Future authorized use of these units will most likely be selective with respect to patients and subject to strict requirements on accountability, recovery, and disposal
